期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性髓系白血病患者血小板输注的阈值探讨 被引量：2

下载PDF
导出
摘要 目的:探讨急性非淋巴细胞白血病(AML)患者输注血小板的阈值。方法:回顾分析180例AML患者的临床资料,依据血小板数值大小将患者分为3组,比较患者在接受诱导缓解化疗、巩固化疗及强化化疗期间血小板计数<20×109/L、10×109/L、5×109/L的出血表现。结果:血小板≤5×109/L组与血小板小板≤10×109/L组及血小板≤20×109/L组比较无出血事件发生率减少,轻微出血事件及严重出血事件的发生率无明显升高,最长中位存在时间为7d。结论:血小板等于5×109/L做为AML的血小板输注阈值是安全的。部分伴发热、高白细胞血症的AML患者血小板输注的指征可定为10×109/L或更高。
作者 周淑亚 曹琰
机构地区 陕西省渭南市中心医院
出处 《陕西医学杂志》 CAS 2012年第10期1353-1354,共2页 Shaanxi Medical Journal
关键词 白血病 髓样 急性 药物疗法 联合 血小板输注 参考值
分类号 R733.71 [医药卫生—肿瘤]
  • 相关文献

参考文献5

二级参考文献4

  • 1Heckman KD,Weiner GJ,Davis CS,et al.Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia:10 000/μl versus 20 000/μl.J Clin Oncol,1997,15:1143-1149
  • 2Wandt H,Frank M,Ehninger G,et al.Safety and cost effectiveness of a 10×109/L trigger for prophylactic platelet transfusions compared with the traditional 20×109/L trigger:a prospective comparative trial in 105 patients with acute myeloid leukemia.Blood,1998,91:3601-3606
  • 3Wandt H,Frank M,Gramatzki M,et al.Safety of the 10 000/μl trigger for prophylactic platelet transfusion:prospective multicenter experience in 734 patients with acute myeloid leukemia.Blood,2000,96(suppl):3536a
  • 4Rebulla P,Finazzi G,Marangoni F,et al.The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia.N Engl J Med,1997,337:1870-1875

共引文献41

同被引文献31

  • 1邓家栋 杨崇礼 杨天楹 等.临床血液学[M].上海：上海科学技术出版社,2001.1085-1090.
  • 2高峰.临床输血与检验[M].北京:人民卫生出版社,2008:153-156.
  • 3Lozano M,Mahon A,van der Meer PF,et al.Counting platelets at transfusion threshold levels:impact on the decision to transfuse,A BEST Collaborative-UK NEQAS(H)International Exercise[J].Vox Sang,2013,106:330-336.
  • 4Mintz PD.Transfusion therapy:clinical principles and practice[M].3rd ed.Bethesda:AABB Press,2011:37-165.
  • 5Kahvecioglu D,Erdeve O,Alan S,et al.The impact of evaluating platelet transfusion need by platelet mass index on reducing the unnecessary transfusions in newborns[J].J Matern Fetal Neonatal Med,2014,27:1787-1789.
  • 6Segal HC,Briggs C,Kunka S,et al.Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion[J].Br J Haematol,2005,128:520-525.
  • 7Vamvakas EC,Hitzler WE.Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia:providing patients with the full benefit[J].Clin Lab,2013,59:459-464.
  • 8Estcourt LJ,Birchall J,Lowe D,et al.Platelet transfusions in haematology patients:are we using them appropriately?[J].Vox Sang,2012,103:284-293.
  • 9Estcourt L,Stanworth S,Doree C,et al.Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation[J].Cochrane Database Syst Rev,2012,16:1002-1007.
  • 10Eikenboom JC,van Wordragen R,Brand A.Compliance with prophylactic platelet transfusion trigger in haematological patients[J].Transfus Med,2005,15:45-48.

引证文献2

二级引证文献18

陕西医学杂志
2012年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部